Thank you so much. You've given us so much to think about. I think we could go on and on, digging down further.
The interesting thing you're talking about, Mr. Elliott, is that we're actually going to restrict our flexibility, and I think the reason that this is part of CETA and the TPP is that if CETA isn't ratified, then it comes into force in the TPP. There's an assumption that CETA will be ratified, but we don't know that. We're looking at what's happening in the EU.
My question is really simple. Is there a need for Canada to increase the intellectual property protections that are provided to pharmaceutical products?
I'll start with Ms. Cox and go around the table.